What happened

The event date for this report is 2026-06-12. The rollout follows a serious outbreak of meningitis in Kent earlier this year. The account is based on one supplied report and should be read as a record of conditions known at that point, rather than as a statement about later developments. Students in Northern Ireland up to the age of 25 are to be offered a one-off meningitis vaccine.

The available figures and chronology

The Health Minister Mike Nesbitt announced the Meningococcal B (MenB) programme for adolescents in line with announcements across the UK. Around a million young people are being offered the jab after an outbreak of the disease in Kent this year as well as clusters in other parts of England. These details help define the scale and immediate setting of the event without extending the evidence beyond what the supplied source states. Where a number is an estimate, provisional count, forecast or company claim, it should not be treated as a final independently audited total. The evidence packet does not support assumptions about motives, responsibility or longer-term outcomes beyond the facts described here.

The operational context

It is expected to be made available in Northern Ireland in mid to late July, aimed at those considered to be at the highest risk of Men-B, and in time for the new academic term. Those eligible include; all of the current year 14 age group aged 17-18 and anyone up to 25-years-old attending higher education or a residential further education institution for the first time in Autumn 2026, which was expected to include international students. These details help define the scale and immediate setting of the event without extending the evidence beyond what the supplied source states. Where a number is an estimate, provisional count, forecast or company claim, it should not be treated as a final independently audited total. The evidence packet does not support assumptions about motives, responsibility or longer-term outcomes beyond the facts described here.

What remained uncertain

The vaccination offers protection against serious illnesses like IMD, meningitis and sepsis. Mr Nesbitt said: “MenB is a serious illness and can cause serious health implications amongst young people. These details help define the scale and immediate setting of the event without extending the evidence beyond what the supplied source states. Where a number is an estimate, provisional count, forecast or company claim, it should not be treated as a final independently audited total. The evidence packet does not support assumptions about motives, responsibility or longer-term outcomes beyond the facts described here.

The record at the time

Taken together, the supplied material supports the main development in the headline and the specific details above. It does not establish what happened after 2026-06-12, and no later outcome is inferred here. The report therefore preserves the event-date framing, attributes the account to the available evidence and avoids turning an early figure or stated plan into a settled result. Further official data, technical findings or independent reporting could refine the picture, but those materials were not part of this packet.